Clinical Trials Browser

Not yet recruiting × Interventional × Efficacy and Safety × Clear all

NCT06383078 2024-04-25

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

Phase 2 Not yet recruiting

Efficacy and Safety